Last $1.49 USD
Change Today +0.075 / 5.30%
Volume 393.6K
KOOL On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

cesca therapeutics inc (KOOL) Snapshot

Open
$1.40
Previous Close
$1.42
Day High
$1.54
Day Low
$1.40
52 Week High
01/22/14 - $3.24
52 Week Low
11/25/13 - $0.71
Market Cap
48.6M
Average Volume 10 Days
340.3K
EPS TTM
$-0.41
Shares Outstanding
32.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CESCA THERAPEUTICS INC (KOOL)

cesca therapeutics inc (KOOL) Related Bloomberg News

View More Bloomberg News

cesca therapeutics inc (KOOL) Related Businessweek News

No Related Businessweek News Found

cesca therapeutics inc (KOOL) Details

Cesca Therapeutics Inc. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. It provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells. The company offers the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used to cryopreserve and archive stem cells for transplant and treatment; Res-Q 60 BMC, a device used for the isolation and extraction of specific stem cell populations from bone marrow; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; and Res-Q 60 PRP, which is used for the preparation of autologous platelet rich plasma from a sample of blood at the point of care. It was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. The company was founded in 1986 and is headquartered in Rancho Cordova, California.

66 Employees
Last Reported Date: 12/24/13
Founded in 1986

cesca therapeutics inc (KOOL) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $315.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $61.0K
Vice President of Corporate Development & Sci...
Total Annual Compensation: $240.0K
Vice President of Manufacturing, Engineering ...
Total Annual Compensation: $270.0K
Compensation as of Fiscal Year 2013.

cesca therapeutics inc (KOOL) Key Developments

Cesca Therapeutics Inc. Appoints Tim Lee as Director of International Sales

Cesca Therapeutics Inc. announced the restructuring of its sales, marketing and technical support organization and the appointment of Tim Lee as Director of International Sales. The restructuring will realign Hal Baker from his current role as Vice President of Commercial Operations, to an external consulting and advisory role, which will ensure an orderly and seamless transition of his existing responsibilities with specific attention given to cord blood sales and marketing initiatives. The underlying areas of Mr. Baker's functional leadership are to be divided within Cesca's new structure for maximum focus on growing each area of the business. In the newly formed role, Director of International Sales, Mr. Lee's primary focus will be to lead global cord blood product sales and services. In addition, as Cesca's clinical programs reach therapeutic market commercialization, Mr. Lee will work directly with its President, Ken Harris, to develop and implement the sales and marketing resources to commercialize and scale these programs.

Cesca Therapeutics Inc. Announces Cessation of Harold Baker as Vice President of Commercial Operations and Marketing

Effective April 10, 2014, Mr. Harold Baker ceased to be employed by Cesca Therapeutics Inc. in his capacity of Vice President of Commercial Operations and Marketing. Mr. Baker will provide consulting services to the Company over a transition period to be mutually agreed upon by the Company and Mr. Baker.

Cesca Therapeutics Inc. Proposes Amendments to Bylaws

Cesca Therapeutics Inc. proposed amendment to bylaws to clarify certain administrative functions, including changing the name to Cesca Therapeutics Inc.; amendment to bylaws to allow the number of directors to be set by the board; amendment to bylaws to provide advance notice for director nominations; amendment to bylaws to provide for a forum for adjudication of disputes.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KOOL:US $1.49 USD +0.075

KOOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chart Industries Inc $76.90 USD -0.67
County Line Energy Corp $0.0051 USD 0.00
Cytomedix Inc $0.56 USD -0.0295
Pall Corp $86.27 USD -0.14
View Industry Companies
 

Industry Analysis

KOOL

Industry Average

Valuation KOOL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.4x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CESCA THERAPEUTICS INC, please visit www.thermogenesis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.